Abstract
Our goal was to compare direct and indirect medical costs and quality of life associated with inpatient vs outpatient autologous hematopoietic stem cell transplantation (AuHSCT). Twenty-one sequential outpatients and 26 inpatients were enrolled on this prospective trial. All candidates for AuHSCT were screened for eligibility for outpatient transplantation. Patients with either breast cancer or hematologic malignancy, insurance coverage for the outpatient procedure, one to three caregivers available to provide 24 h coverage, and no significant comorbidities were eligible to participate. Patients without caregivers or insurance coverage for outpatient transplant were accrued to the study in a consecutive manner as inpatient controls, based on willingness to participate in the quality of life portion of the study and to permit review of their hospital and billing records. Approximately half of all 139 prospective outpatient candidates were ineligible because they lacked a caregiver. Most commonly, the patient without a caregiver was single or widowed or their family and friends were needed to provide childcare. Most caregivers were college educated from families with incomes greater than $80 000. Indirect costs to the caregivers totaled a median of $2520 (range $684–$4508), with the majority attributed to lost ‘opportunity costs’. Overall, there were significant differences in the total costs of treatment for inpatient vs outpatient AuHSCT ($40 985 vs $29 210, P < 0.01)). In general, no significant differences were detected between inpatient and outpatient scores on quality of life measures. Although significant cost savings were associated with outpatient transplantation, this approach was applicable to only half of our otherwise eligible candidates because of a lack of caregivers. The financial burden associated with the caretaking role may underlie this finding.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dix SP, Geller RB . High-dose chemotherapy with autologous stem cell rescue in the outpatient setting Oncology 2000 14: 171 185
Peters WP, Ross M, Vredenburgh JJ et al. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer Semin Oncol 1994 21: 25 31
Meisenberg BR, Miller WE, McMillan R et al. Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and non-hematologic malignancies J Clin Oncol 1997 15: 11 17
Jagannath S, Vesole DH, Zhang M et al. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma Bone Marrow Transplant 1997 20: 445 450
Weaver CH, Schwartzberg L, Zhen B et al. High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: Results of outpatient treatment in community cancer centers Bone Marrow Transplant 1997 20: 753 760
Gluck S, des Rochers C, Cano C et al. High-dose chemotherapy followed by autologous blood stem cell transplantation: a safe and effective outpatient approach Bone Marrow Transplant 1997 20: 431 434
Rizzo JD, Vogelsang GB, Krumm S et al. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol 1999 17: 2811 2818
Seropian S, Nadkarni R, Killella AP et al. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: outpatient treatment is a viable option Bone Marrow Transplant 1999 23: 599 605
Meisenberg BR, Ferran K, Hollenback K et al. Reduced charges and costs associated with outpatient autologous stem cell transplantation Bone Marrow Transplant 1998 21: 927 932
Freeman MB, Vose JM, Bennett CL et al. Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989–95 Bone Marrow Transplant 1999 24: 679 684
Cella DF, Tulsky DS, Gray G et al. The Functional Assesment of Cancer Therapy (FACT) Scale: development and validation of the general measure J Clin Oncol 1993 11: 570 579
Guadagnoli E, Mor V . Measuring cancer patients’ affect: revision and psychometric properties of the profile of moods states (POMS) Psych Assess 1989 1: 150 154
Horowitz M, Wilner M, Alvarez W . Impact of event scale: a measure of subjective stress Psychosom Med 1979 41: 209 218
Muurinen JM . The economics of informal care Medical Care 1986 24: 1007 1017
Brouwer WB, Koopmanschap MA, Rutten FF . Patient and informal caregiver time in cost-effectiveness analysis Int J Tech Assess Health Care 1998 14: 505 513
Sharma N, Hendrix L, O'Connell K et al. Obstacles to performing high-dose therapy with peripheral blood stem cell rescue in the outpatient setting Blood 1997 90 (Suppl. 1): 116a
Grimm PM, Zawacki KL, Mock V et al. Caregiver responses and needs: an ambulatory bone marrow transplant model Cancer Prac 2000 8: 120 128
Laurence CC, Gilbert CJ, Peters WP . Evaluation of symptom distress in a bone marrow transplant outpatient environment Ann Pharmacother 1996 30: 941 945
Acknowledgements
This study was supported in part by the Department of Defense, DAMD17-96-2-6013, NIH/NCI P30 CA60553-09, and the NIH/NCRR M01 RR00048.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frey, P., Stinson, T., Siston, A. et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant 30, 741–748 (2002). https://doi.org/10.1038/sj.bmt.1703676
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703676
Keywords
This article is cited by
-
Psychosocial assessment practices for hematopoietic stem cell transplantation: a national survey study
Bone Marrow Transplantation (2023)
-
The Need for Specialized Oncology Training for Clinical Ethicists
HEC Forum (2022)
-
Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice
Supportive Care in Cancer (2019)
-
Adaptation of Coping Together - a self-directed coping skills intervention for patients and caregivers in an outpatient hematopoietic stem cell transplantation setting: a study protocol
BMC Health Services Research (2018)
-
Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study
Bone Marrow Transplantation (2016)